Asthma

The Pharmacy Times® Asthma resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
Benralizumab Approved by FDA as Self-Administered Auto-Injector for Asthma
Benralizumab is a monoclonal antibody that binds directly to the IL-5 receptor alpha on eosinophils and attracts natural killer cells to induce rapid depletion of eosinophils via programmed cell death.
Case Study: Albuterol
Can MH safely take albuterol instead of levalbuterol?
Paracetamol Use During Pregnancy Is Not Associated With Higher Asthma Risk in Children
The results of a study of almost 500,000 women indicate that taking paracetamol or other painkillers during pregnancy does not increase the risk of asthma in children.
Asthma Watch: Trelegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication
Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.
Asthma Watch: Traffic-Related Air Pollution Causes Asthma for Millions of Children
The results of a new study by George Washington University show that about 4 million children worldwide develop asthma annually because of nitrogen dioxide inhalation through air pollution.
May 31 Pharmacy Week in Review: American Society of Clinical Oncology Meeting Coverage Coming, Behaviors and Psychosocial Stressors May Increase Asthma Risk in Adolescents
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Investigational Inhalational Therapy Shows Benefits Over Standard Asthma Treatment in Study
The new phase 2 data for an investigational once-daily, fixed dose combination currently in development for the treatment of inadequately controlled asthma was presented at the 2019 Annual International Congress of the American Thoracic Society (ATS) in Dallas.
Trellegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication
Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.
Helping Patients Breathe Easier
Pharmacists have a great opportunity to educate patients about how to stay healthy and counsel those in need of symptom relief about their allergy treatment options.
Letter from the Chairman: Helping Patients Breathe Easier
Patients can breathe easier knowing that their local pharmacists are ideally positioned to help them manage their allegy, asthma and COPD conditions.
Asthma May Be More Common in Opioid-Dependent Patients
Previous research has found illicit opiates may exacerbate asthma. 
+ Load More